Your browser is no longer supported. Please, upgrade your browser.
OPTN [NASD]
OptiNose, Inc.
Index- P/E- EPS (ttm)-2.20 Insider Own0.90% Shs Outstand48.91M Perf Week-3.07%
Market Cap212.98M Forward P/E- EPS next Y-1.35 Insider Trans-41.95% Shs Float30.90M Perf Month-2.38%
Income-100.90M PEG- EPS next Q-0.46 Inst Own94.80% Short Float17.31% Perf Quarter13.22%
Sales43.90M P/S4.85 EPS this Y2.00% Inst Trans0.39% Short Ratio11.78 Perf Half Y-21.71%
Book/sh0.57 P/B7.21 EPS next Y34.80% ROA-59.30% Target Price- Perf Year-53.98%
Cash/sh2.76 P/C1.49 EPS next 5Y- ROE-294.60% 52W Range3.14 - 10.00 Perf YTD-0.72%
Dividend- P/FCF- EPS past 5Y- ROI-75.50% 52W High-58.90% Beta-
Dividend %- Quick Ratio3.80 Sales past 5Y- Gross Margin83.20% 52W Low30.89% ATR0.23
Employees102 Current Ratio4.00 Sales Q/Q24.20% Oper. Margin- RSI (14)45.09 Volatility4.40% 6.09%
OptionableNo Debt/Eq3.79 EPS Q/Q37.60% Profit Margin- Rel Volume1.18 Prev Close4.09
ShortableYes LT Debt/Eq3.79 EarningsNov 05 BMO Payout- Avg Volume454.34K Price4.11
Recom1.80 SMA20-3.43% SMA50-4.19% SMA200-10.19% Volume536,791 Change0.49%
Dec-18-19Initiated Cowen Outperform $25
Aug-08-18Initiated Cantor Fitzgerald Overweight
Dec-21-20 10:00AM  
Dec-11-20 05:35PM  
Dec-01-20 04:30PM  
Nov-18-20 08:33AM  
Nov-17-20 10:42AM  
Nov-07-20 09:31AM  
Nov-05-20 07:00AM  
06:15AM  
Oct-22-20 07:00AM  
Sep-29-20 09:30AM  
Sep-14-20 08:00AM  
Aug-14-20 01:11PM  
08:37AM  
08:04AM  
Aug-13-20 04:26PM  
Aug-11-20 12:21PM  
12:14PM  
Aug-05-20 12:30AM  
Aug-04-20 09:15AM  
07:00AM  
Jul-30-20 04:01PM  
Jul-29-20 04:01PM  
Jul-16-20 03:27PM  
Jul-09-20 08:09AM  
Jul-05-20 03:05PM  
Jun-30-20 08:00AM  
Jun-22-20 08:30AM  
Jun-19-20 10:00AM  
May-27-20 04:30PM  
May-26-20 09:00AM  
May-14-20 04:15PM  
May-08-20 03:00PM  
May-07-20 04:01PM  
Apr-30-20 04:15PM  
Apr-29-20 08:47AM  
Apr-11-20 10:01AM  
Mar-16-20 09:15AM  
Mar-05-20 07:45AM  
06:30AM  
Feb-27-20 04:30PM  
Feb-26-20 12:30PM  
Feb-19-20 07:00AM  
Dec-17-19 07:03PM  
08:30AM  
Dec-10-19 12:12PM  
Nov-26-19 04:01PM  
Nov-21-19 09:00AM  
Nov-20-19 04:00PM  
Nov-17-19 08:00AM  
Nov-12-19 04:01PM  
Nov-07-19 06:02PM  
Nov-05-19 10:33AM  
Nov-01-19 08:00AM  
Oct-04-19 08:00AM  
08:00AM  
Sep-27-19 08:00AM  
Sep-26-19 08:15AM  
07:00AM  
Sep-17-19 04:01PM  
Sep-12-19 04:05PM  
Sep-11-19 01:34PM  
Aug-13-19 03:45PM  
Aug-12-19 10:23PM  
05:25PM  
04:02PM  
02:30PM  
Aug-05-19 10:30AM  
Aug-01-19 04:30PM  
Jul-11-19 12:13PM  
Jun-20-19 08:00AM  
Jun-19-19 04:30PM  
May-22-19 10:42AM  
May-09-19 11:23AM  
08:55AM  
07:46AM  
07:00AM  
May-02-19 10:33AM  
Apr-27-19 09:01AM  
Apr-25-19 07:00AM  
Mar-21-19 11:06AM  
Mar-06-19 12:22PM  
07:00AM  
Feb-27-19 07:00AM  
Feb-19-19 07:00AM  
Feb-15-19 07:00AM  
Feb-04-19 12:46PM  
07:00AM  
Dec-25-18 10:28AM  
Dec-13-18 07:56AM  
Dec-11-18 07:50AM  
07:00AM  
Dec-10-18 07:00AM  
Dec-05-18 04:30PM  
Nov-26-18 05:29PM  
Nov-13-18 10:15AM  
09:11AM  
07:00AM  
Oct-31-18 04:30PM  
Oct-22-18 08:10AM  
Oct-03-18 07:00AM  
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, and throat; and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary optinose exhalation delivery system that delivers a topically-acting and anti-inflammatory corticosteroid for the treatment of chronic rhinosinusitis with and without nasal polyps. It is also developing XHANCE, which is in Phase IIIb clinical trial for the treatment of chronic sinusitis; and OPN-300 for the treatment of Prader-Willi syndrome, a rare genetic obesity disorder, as well as autism spectrum disorder. The company has a license agreement with Currax Pharmaceuticals LLC for the commercialization of Onzetra Xsail (sumatriptan nasal powder) to treat migraine in adults; and Inexia Limited to develop, manufacture, import, and sale products containing orexin receptor agonist and/or orexin receptor positive modulator molecules for the treatment, diagnosis, or prevention of human diseases or conditions associated primarily with orexin receptor agonism and orexin receptor positive modulation. OptiNose, Inc. was founded in 2010 and is headquartered in Yardley, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Mahmoud Ramy APresident and COODec 23Option Exercise1.6328,34246,19754,573Dec 29 05:44 PM
Mahmoud Ramy APresident and COODec 23Option Exercise1.6385,016138,576216,504Dec 29 05:44 PM
Miller Peter KChief Executive OfficerDec 23Option Exercise1.6386,639141,222162,359Dec 29 05:43 PM
Miller Peter KChief Executive OfficerDec 23Option Exercise1.63140,068228,311395,085Dec 29 05:43 PM
Mahmoud Ramy APresident and COODec 23Sale4.037,83531,60746,738Dec 29 05:44 PM
Mahmoud Ramy APresident and COODec 23Sale4.0323,43694,546193,068Dec 29 05:44 PM
Miller Peter KChief Executive OfficerDec 23Sale4.0323,86396,177138,496Dec 29 05:43 PM
Miller Peter KChief Executive OfficerDec 23Sale4.0338,591155,537356,494Dec 29 05:43 PM
Miller Peter KChief Executive OfficerDec 02Option Exercise1.63102,268166,697142,638Dec 04 05:43 PM
Miller Peter KChief Executive OfficerDec 02Option Exercise1.63121,812198,554334,540Dec 04 05:43 PM
Miller Peter KChief Executive OfficerDec 02Sale4.3233,330143,996109,308Dec 04 05:43 PM
Miller Peter KChief Executive OfficerDec 02Sale4.3341,470179,395293,070Dec 04 05:43 PM
Miller Peter KChief Executive OfficerNov 25Option Exercise1.6318,39329,98152,539Nov 25 07:27 PM
Miller Peter KChief Executive OfficerNov 25Option Exercise1.6337,98561,916237,860Nov 25 07:27 PM
Mahmoud Ramy APresident and COONov 25Option Exercise1.633,4895,68728,899Nov 25 07:27 PM
Mahmoud Ramy APresident and COONov 25Option Exercise1.6310,46717,061142,191Nov 25 07:27 PM
Mahmoud Ramy APresident and COONov 25Sale4.329774,21627,922Nov 25 07:27 PM
Mahmoud Ramy APresident and COONov 25Sale4.322,93112,649139,260Nov 25 07:27 PM
Miller Peter KChief Executive OfficerNov 25Sale4.305,14122,11847,398Nov 25 07:27 PM
Miller Peter KChief Executive OfficerNov 25Sale4.3010,61745,678227,243Nov 25 07:27 PM
Miller Peter KChief Executive OfficerNov 24Option Exercise1.6316,30226,57244,867Nov 25 07:27 PM
Miller Peter KChief Executive OfficerNov 24Option Exercise1.6333,65354,854222,007Nov 25 07:27 PM
Mahmoud Ramy APresident and COONov 24Option Exercise1.6312,49620,36833,627Nov 25 07:27 PM
Mahmoud Ramy APresident and COONov 24Option Exercise1.6337,46661,070156,363Nov 25 07:27 PM
Mahmoud Ramy APresident and COONov 24Sale4.393,53315,49430,094Nov 25 07:27 PM
Mahmoud Ramy APresident and COONov 24Sale4.3910,59346,455145,770Nov 25 07:27 PM
Miller Peter KChief Executive OfficerNov 24Sale4.394,60920,21240,258Nov 25 07:27 PM
Miller Peter KChief Executive OfficerNov 24Sale4.399,51541,727212,492Nov 25 07:27 PM
Miller Peter KChief Executive OfficerNov 23Option Exercise1.6362,488101,85569,334Nov 25 07:27 PM
Miller Peter KChief Executive OfficerNov 23Option Exercise1.63129,021210,304272,531Nov 25 07:27 PM
Mahmoud Ramy APresident and COONov 23Option Exercise1.6347,89878,07452,381Nov 25 07:27 PM
Mahmoud Ramy APresident and COONov 23Option Exercise1.63143,611234,086212,593Nov 25 07:27 PM
Mahmoud Ramy APresident and COONov 23Sale4.5013,74661,85238,635Nov 25 07:27 PM
Mahmoud Ramy APresident and COONov 23Sale4.5041,214185,447171,379Nov 25 07:27 PM
Miller Peter KChief Executive OfficerNov 23Sale4.5017,93380,69151,401Nov 25 07:27 PM
Miller Peter KChief Executive OfficerNov 23Sale4.5037,027166,607235,504Nov 25 07:27 PM
Mahmoud Ramy APresident and COONov 19Option Exercise1.631,4062,2925,365Nov 20 04:11 PM
Mahmoud Ramy APresident and COONov 19Option Exercise1.634,2126,86671,635Nov 20 04:11 PM
Miller Peter KChief Executive OfficerNov 19Option Exercise1.632,1473,5008,192Nov 20 04:11 PM
Miller Peter KChief Executive OfficerNov 19Option Exercise1.633,4715,658145,704Nov 20 04:11 PM
Mahmoud Ramy APresident and COONov 19Sale5.061,2856,50670,350Nov 20 04:11 PM
Miller Peter KChief Executive OfficerNov 19Sale5.066553,3167,537Nov 20 04:11 PM
Miller Peter KChief Executive OfficerNov 19Sale5.061,0595,362144,645Nov 20 04:11 PM
Mahmoud Ramy APresident and COONov 18Option Exercise1.633,2785,3436,022Nov 20 04:11 PM
Mahmoud Ramy APresident and COONov 18Option Exercise1.639,81916,00573,638Nov 20 04:11 PM
Miller Peter KChief Executive OfficerNov 18Option Exercise1.635,0058,1589,194Nov 20 04:11 PM
Miller Peter KChief Executive OfficerNov 18Option Exercise1.638,09113,188147,356Nov 20 04:11 PM
Miller Peter KChief Executive OfficerNov 18Sale5.001,5187,5907,676Nov 20 04:11 PM
Miller Peter KChief Executive OfficerNov 18Sale5.002,45412,270144,902Nov 20 04:11 PM
Mahmoud Ramy APresident and COONov 18Sale5.009944,9705,028Nov 20 04:11 PM
Mahmoud Ramy APresident and COONov 18Sale5.002,97814,89070,660Nov 20 04:11 PM
Goldan Keith A.Chief Financial OfficerSep 23Buy3.902,5009,7439,751Sep 23 04:47 PM
Marino Michael F IIIChief Legal Officer & Corp SecSep 04Buy4.251,0004,25017,570Sep 09 02:53 PM
Marino Michael F IIIChief Legal Officer & Corp SecSep 01Buy4.301,0004,30016,570Sep 09 02:53 PM
Marino Michael F IIIChief Legal Officer & Corp SecAug 21Buy5.031,0005,03015,570Aug 25 02:00 PM
Marino Michael F IIIChief Legal Officer & Corp SecAug 20Buy5.251,0005,25014,570Aug 25 02:00 PM
Marino Michael F IIIChief Legal Officer & Corp SecAug 18Buy5.105002,55013,003Aug 18 06:49 PM
Marino Michael F IIIChief Legal Officer & Corp SecAug 17Buy5.212,00010,41012,503Aug 18 06:49 PM
Marino Michael F IIIChief Legal Officer & Corp SecAug 14Buy5.103,56718,20113,570Aug 18 06:49 PM
Mahmoud Ramy APresident and COOAug 11Option Exercise1.634,8617,9235,567Aug 12 07:27 PM
Mahmoud Ramy APresident and COOAug 11Option Exercise1.6314,54923,71572,268Aug 12 07:27 PM
Miller Peter KChief Executive OfficerAug 11Option Exercise1.637,42512,1038,500Aug 12 07:26 PM
Miller Peter KChief Executive OfficerAug 11Option Exercise1.6311,98819,540146,227Aug 12 07:26 PM
Miller Peter KChief Executive OfficerAug 11Sale7.002,56217,9445,938Aug 12 07:26 PM
Miller Peter KChief Executive OfficerAug 11Sale7.004,13828,983142,089Aug 12 07:26 PM
Mahmoud Ramy APresident and COOAug 11Sale7.001,67811,7533,889Aug 12 07:27 PM
Mahmoud Ramy APresident and COOAug 11Sale7.005,02235,17467,246Aug 12 07:27 PM
Mahmoud Ramy APresident and COOAug 10Option Exercise1.631,6822,7421,682Aug 12 07:27 PM
Mahmoud Ramy APresident and COOAug 10Option Exercise1.635,0228,18660,637Aug 12 07:27 PM
Miller Peter KChief Executive OfficerAug 10Option Exercise1.632,5624,1762,562Aug 12 07:26 PM
Miller Peter KChief Executive OfficerAug 10Option Exercise1.634,1406,748136,645Aug 12 07:26 PM
Miller Peter KChief Executive OfficerAug 10Sale7.008846,1881,678Aug 12 07:26 PM
Miller Peter KChief Executive OfficerAug 10Sale7.001,42910,003135,216Aug 12 07:26 PM
Mahmoud Ramy APresident and COOAug 10Sale7.005804,0601,102Aug 12 07:27 PM
Mahmoud Ramy APresident and COOAug 10Sale7.001,73312,13158,904Aug 12 07:27 PM
O'Neil Robert PDirectorMar 09Buy5.325,00026,5967,000Mar 09 04:33 PM
Scodari Joseph CDirectorMar 06Buy5.708,70049,60521,230Mar 09 07:07 AM